Serum Anti-Müllerian Hormone: A Potential Biomarker for Polycystic Ovary Syndrome

    Ashutosh Halder, Hemant Kumar, Mona Sharma, Manish Jain, Amanpreet Kaur Kalsi, Shivam Pandey
    Studysummary This study suggests that anti-Müllerian hormone (AMH) is the most promising biomarker for diagnosing polycystic ovary syndrome (PCOS), especially in women with phenotype A and D.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results